I. Important Notes
This semi-annual report summary is derived from the full semi-annual report. To fully understand the company's operating results, financial position, and future development plans, investors should carefully read the full semi-annual report on the media designated by the China Securities Regulatory Commission.
All directors attended the board meeting to review this report.
Non-standard audit opinion:
□ Applicable ☒ Not applicable
Profit distribution plan or capital reserve conversion plan for the reporting period reviewed by the Board of Directors:
The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert capital reserves into share capital.
Priority share profit distribution plan for the reporting period approved by the Board of Directors:
II. Company Profile
1. Company Profile
| Stock Abbreviation | Innovation Medical | Stock Code | 002173 |
|---|---|---|---|
| Stock Exchange | Shenzhen Stock Exchange | ||
| Contact Person | Board Secretary | Securities Affairs Representative | |
| Name | Guo Lidan | Zhao Yang | |
| Office Address | Pearl Industrial Park, Shanhua Lake, Zhuji City, Zhejiang Province | Pearl Industrial Park, Shanhua Lake, Zhuji City, Zhejiang Province | |
| Telephone | 0575-87160891 | 0575-87160891 | |
| cxyl002173@126.com | cxyl002173@126.com |
2. Key Accounting Data and Financial Indicators
Whether the company needs to retroactively adjust or restate previous years' accounting data:
□ Yes ☒ No